Email This Content
Send an email to a colleague about this document. Non-subscribers may purchase the article.© Copyright 2010 WINDHOVER INFORMATION INC., All Rights Reserved
Windhover Information Inc. - Health Care Business Intelligence
Delivering essential analysis and insights to top health care executives, investment professionals, and industry consultants
Speeding its entry into the European cancer drug market, Cephalon has agreed to acquire privately held specialty pharmaceuticals company Zeneus Pharma for $360mm in cash.
For information about Strategic Transactions, Elsevier Business Intelligence's comprehensive database of biopharmaceutical, medical device and diagnostic dealmaking activity, please click here.
Questions? Call Toll Free (800) 332-2181 or (908) 547-2159.
If you are already a subscriber, please log in for complete access. 
Questions? Call Toll Free (800) 332-2181 or (908) 547-2159.
Click an article title to see a free preview.
Another Twist in Myocet Plot With $55 Million Zoticon-Led Financing for Sopherion, Start-Up 3/1/2009
